Barely Significant
← all excerpts

Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH.

Cell Death Differ · 2020 · PMC7308387 · PMID 31959914

Europe PMCDOI
2
hedged sentences
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

extremely significantp < 0.001actually significant
highly significantp < 0.001actually significant
Significant differences are indicated using the standard Michelin Guide scale (* p < 0.05, significant; ** p < 0.01, highly significant; *** p < 0.001, extremely significant).

also in 7,787 other papers

a clear trendno p-value reported
Similarly to CTPI-2 treatment, Alb/Cre + :Slc25a1 −/− mice showed a clear trend of improvement in the ability to clear blood glucose relative to wild-type mice (Supplementary Fig.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.